Integration of genetic, cellular, neural systems and cognitive investigations will enable a thorough understanding of SYT1-associated neurodevelopmental disorder with the prospect of precision medicine targeting each individual’s symptoms and underlying mechanisms. This evidence concerns the gene SYT1 and neurodevelopmental disorder.